Neurologic Complications in Oral Polio Vaccine Recipients
J Pediatr 108:878-881, Gaebler,J.W., 1986
Lathyrism:Evidence for Role of the Neuroexcitatory Aminoacid BOAA
Lancet 2:1066-1067, Spencer,P.S.,et al, 1986
A Long-Term Follow-Up Study of Patients with Post-Poliomyelitis Neuromuscular Symptoms
NEJM 314:959-963, Dalakas,M.C.,et al, 1986
A Double-Blind, Placebo-Controlled Trial of TRH in Amyotrophic Lateral Sclerosis
Neurol 36:141-145, Caroscio,J.T.,et al, 1986
Controlled Trial of Thyrotropin Releasing Hormone in Amyotrophic Lateral Sclerosis
Neurol 36:146-151, Brooke,M.H.,et al, 1986
Amyotrophic Lateral Sclerosis:Effects of Administration of Thyrotropin-Releasing Hormone
Neurol 36:152-159, Mitsumoto,H.,et al, 1986
Amyotrophic Lateral Sclerosis, Associated Clinical Disorders & Immunological Evaluations
Arch Neurol 43:234-238, Appel,S.H.,et al, 1986
Familial Adult Motor Neuron Disease:Amyotrophic Lateral Sclerosis
Neurol 36:511-517, Mulder,D.W.,et al, 1986
Neonatal Paralytic Poliomyelitis
Arch Neurol 43:192-194, Bergeisen,G.H.,et al, 1986
Alzheimer's Disease, Parkinson's Disease, & Motoneurone Disease:Abiotropic Interaction Between Ageing & Environment
Lancet 2:1067-1068, Calne,D.B.,et al, 1986
Location of the Gene for X-Linked Spinal Muscular Atrophy
Neurol 36:1595-1598, Fischbeck,K.H.,et al, 1986
Late Sequelae of Poliomyelitis
Editorial, Lancet 2:1195-11961986., , 1986
Slow Resolution of Multifocal Weakness & Fasciculation:A Reversible Motor Neuron Syndrome
Neurol 36:1260-1263, Chad,D.A.,et al, 1986
Motor Neuron Disease & Plasma Cell Dyscrasia
Neurol 36:1429-1436, Shy,M.E.,et al, 1986
From Benign Fasciculations & Cramps to Motor Neuron Disease
Neurol 36:997-998, Shepherd-Fleet,W.&Watson,R.T., 1986
Low-Dose Bromocriptine Therapy in Parkinson's Disease:Double-Blind, Placebo-Controlled Study
Neurol 36:291-293, Staal-Schreinemachers,A.L.,et al, 1986
Dopamine D2 Receptor Density Remains Constant in Treated Parkinson's Disease
Ann Neurol 19:487-492, Guttman,M.,et al, 1986
Delayed Postirradiation Lower Motor Neuron Syndrome
Ann Neurol 19:308-309, Gallego,J.,et al, 1986
Primary Amyloidosis with Peripheral Neuropathy & Signs of Motor Neuron Disease
Neurol 36:1125-1127, Abarbanel,J.M.,et al, 1986
Metoclopramide-Induced Parkinsonism in Hemodialysis Patients
Arch Int Med 146:2070-2071, Sirota,R.A.,et al, 1986
Tardive Dyskinesia Associated with High-Dose Intravenous Metoclopramide
NEJM 315:518-519, Breitbart,W., 1986
Post-Polio Syndrome
J Med Assoc Ga 74:510-511, Bailey,A.A., 1985
Amyotrophic Lateral Sclerosis:Part 1. Clinical Features, Pathology, & Ethical Issues in Management
Ann Neurol 18:271-280, Tandan,R.,et al, 1985
Amytrophic Lateral Sclerosis:Part 2, Etiopathogenesis
Ann Neurol 18:419-431, Tandan,R.,et al, 1985
Isolation of LAV/HTLV-III From a Patient with Amyotrophic Lateral Sclerosis
NEJM 313:324-325, Hoffman,P.M.,et al, 1985
ALS & Pet Exposure
Neurol 35:717-720, Tarras,S.,et al, 1985
Low Doses of Dopamine Agonists in the Long-Term Treatment of Macroprolactinomas
NEJM 313:656-659, Liuzzi,A.,et al, 1985
Cerebrospinal Fluid Rhinorrhea During Treatment with Bromocriptine for Prolactinoma
Neurol 35:1193-1195, Kok,J.G.,et al, 1985
Leukaemia & the Central Nervous System
Editorial, Lancet 1:1196-11981985., , 1985
Low-Dose Bromocriptine Therapy in Parkinson's Disease
Arch Neurol 42:586-588, Pfeiffer,R.F.,et al, 1985
Mesulergin (CU32-085) in the Treatment of Parkinson's Disease
Ann Neurol 17:334-336, Pfeiffer,R.F.,et al, 1985
Neuroleptic Malignant Syndrome
NEJM 313:163-166, Guze,B.H.,et al, 1985
Extrapyramidal Reactions with Metoclopramide
BMJ 291:930-932, Bateman,D.N.,et al, 1985
Prolactinomas
Editorial, BMJ 290:182-1841985., Grossman,A.,et al, 1985
Low Dosages of Bromocriptine Added to Levodopa in Parkinson's Disease
Neurol 35:199-206, Maier,M.M.,et al, 1985
Long-Term Study of Pergolide in Parkinson's Disease
Neurol 35:296-299, Jankovic,J., 1985
Placebo-Controlled Study of Mesulergine in Parkinson's Disease
Neurol 35:161-165, Jankovic,J.,et al, 1985
Hyperthermia after Discontinuance of Levodopa & Bromocriptine Therapy:Impaired Dopamine Receptors a Possible Cause
Neurol 35:258-261, Figa-Talamanca,L.,et al, 1985
Progressive Dementia, Visual Deficits, Amyotrophy, & Microinfarcts
Neurol 35:789-796, Kaplan,J.G.,et al, 1985
Pimozide for Tourette's Disorder
Medical Letter 27:3-4, , 1985
Pathological Laughter & Crying
In Frederiks, J. A. M. (Ed) Handbook of Clinical Neurology, Elsevier Science Publ, 45:219, Poeck,K., 1985
Psychotic Reactions During Treatment of Pituitary Tumours with Dopamine Agonists
BMJ 289:1101-1103, Turner,T.H.,et al, 1984
Effect of Dopamine Agonist Withdrawal After Long-Term Therapy in Prolactinomas
Lancet 2:187-192, Johnston,D.G.,et al, 1984
Pergolide in the Treatment of Parkinson's Disease
Neurol 34:983-986, Mear,J.,et al, 1984
Prolonged Metoclopramide-Induced Dyskinetic Reaction
Neurol 34:238-239, Leopold,N.A., 1984
Amyotrophic Lateral Sclerosis:A Double-Blind Crossover Trial of Thyrotropin-Releasing Hormone
JNNP 47:1332-1334, Imoto,K.,et al, 1984
Nystagmus in Motor Neuron Disease:Clinicopathological Study of Two Cases
Ann Neurol 16:71-77, Kushner,M.J.,et al, 1984
Sudden Infant Death Syndrome Caused by Poliomyelitis
Arch Neurol 41:775-777, Dunne,J.W.,et al, 1984
Inhibition of Terminal Axonal Sprouting by Serum From Patients with Amyotrophic Lateral Sclerosis
NEJM 311:933-939, Gurney,M.E.,et al, 1984
Familial Occurrence of Amyotrophic Lateral Sclerosis, Parkinsonism, & Dementia
Ann Neurol 16:642-648, Schmitt,H.P.,et al, 1984